Work

OA12.04 Nivolumab After Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Randomized I-SABR Trial

Year: 2023

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2023.09.069

Authors: J.Y. Chang, S.H. Lin, W. Dong, Z. Liao, S. Gandhi, S.G. Chun, C.M. Gay, J. Zhang, F.V. Fossella, G.R. Blumenschein, T. Cascone, X. Le, J.V. Pozadzides, A. Tsao, A. Mehmet, J.W. Welsh, V. Verma, I.I. Wistuba, J. Lee, J. Heymach

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4388069710

Cites:

Cited by:

Related to: 10